Teva and Allergan reach $161 million opioid settlement with West Virginia

[ad_1]

Hello, everyone, and how are you today? A steely gray sky is hovering this morning over the Pharmalot campus, where the short person is sleeping in and the official mascot is resting before a play date. As for us, we are foraging for interesting stories and quaffing cups of stimulation, as you might have guessed. Our choice today is bourbon pecan. And you? Is your schedule filled with meetings and deadlines and what-not? It should be, yes? Well, to help you along, here are some tidbits. Hope you conquer the world today, and do keep us in mind when you see something fascinating. …

Teva Pharmaceutical and Allergan, a unit of AbbVie,  reached a settlement worth $161.5 million to resolve claims the companies fueled an opioid epidemic in West Virginia, Reuters notes. The state had accused Teva and Allergan of deceiving prescribers about the risks of opioids when marketing their drugs for the treatment of chronic pain. The misleading marketing led to an increase in substance abuse and overdose deaths, according to West Virginia’s complaint. The settlement ended a trial that had been proceeding for two months in Kanawha County Circuit Court. The companies did not admit wrongdoing as part of the settlement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED



[ad_2]

Source link

AsadKhan92

Learn More →

Leave a Reply

Your email address will not be published.